Ark Invest’s daily transparency shows Cathie Wood adding three sharply‑priced names to her portfolio – Netflix, Oklo and Intuitive Surgical – as she hunts for value in a volatile market.
Key points
- Ark Invest added to its holdings in Netflix, Oklo and Intuitive Surgical, three stocks that have fallen sharply this year.
- Netflix remains the dominant premium streaming service but faces revenue guidance and staffing challenges that have pressured its share price.
- Oklo’s nuclear‑technology business is in early revenue stages, with long‑term growth potential but near‑term profitability still distant.
- Intuitive Surgical’s robotic‑surgery platform continues to generate earnings beats, even as growth slows and competition intensifies.
Ark Invest disclosed that it increased its positions in Netflix (NFLX), Oklo (OKLO) and Intuitive Surgical (ISRG) on Wednesday, adding to existing holdings in each company. All three shares have lost between 7% and 80% over the past twelve months, according to the source.
Netflix’s stock hit a two‑year low after the streaming giant issued revenue guidance that fell short of analyst expectations and announced a 6% workforce reduction. The company’s ad‑supported revenue now represents only about 5% of its total, and its outlook for the current quarter is below consensus estimates. Despite the setbacks, the report notes that Netflix still commands more than 300 million global members and trades at roughly 17 times next‑year earnings estimates, a valuation the source describes as “intriguingly priced.”
Netflix: A premium streamer at a discount
Oklo, a next‑generation nuclear‑energy firm, has seen its market value tumble roughly 86% from its 2025 peak. The company recently began generating revenue and is projected to earn about $312 million by 2030, though profitability is not expected for at least five years. The source highlights that nearly half of Oklo’s $5.2 billion market cap is backed by cash, underscoring the stock’s volatility.
Intuitive Surgical, known for its da Vinci robotic‑surgery platform, declined about 7% over the past year and has lost almost a quarter of its value in 2026. While revenue growth is expected to slow to 13% in the upcoming quarter – the weakest pace in three years – the company continues to post double‑digit earnings beats. The report suggests that competitive threats could present an opportunity, given the high switching costs associated with the da Vinci system.
Oklo: Nuclear tech still in early‑stage growth
Cathie Wood’s moves reflect a “bargain‑hunting” approach, targeting companies that remain leaders in their sectors despite recent price declines. The source does not provide Wood’s specific rationale for each addition, but Ark’s daily filing practice makes the trades publicly visible.
Reader questions
Why is Cathie Wood buying stocks that have dropped in value?
According to the source, Wood’s strategy involves seeking “bargain” opportunities in companies she believes retain strong long‑term fundamentals despite recent price declines.
What are the growth expectations for Oklo?
Analysts cited in the source project Oklo could generate about $312 million in revenue by 2030, but profitability is not expected for at least five years.
How does Intuitive Surgical’s valuation compare to its earnings outlook?
The source notes that Intuitive Surgical has consistently delivered double‑digit earnings beats, though revenue growth is expected to slow to 13% in the next quarter.
Source: finance.yahoo.com
